What is CAGR? What does CAGR table indicate for Lincoln Pharmaceuticals Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Lincoln Pharmaceuticals Ltd Stock Analysis

Q: Is Lincoln Pharmaceuticals Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Lincoln Pharmaceuticals Ltd and arrived at the following conclusion.

Small Cap

Evaluated by 895 users | BSE: 531633 | NSE: LINCOLN |
Pharmaceuticals & Drugs

Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It...

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis P

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Capital Employed	6.73%	6.47%	8.66%	10.3%	11.5%	13.23%	14.04%	12.8%	16.2%	14.73%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	166	175	192	208	223	311	304	325	353	376
Y-o-Y Gr. Rt.	-	5.4%	9.6%	8.8%	7.1%	39.2%	-2.1%	6.8%	8.6%	6.5%
Adjusted EPS (Rs.)	2.02	1.95	4.63	7.2	8.2	12.18	13.62	15.09	21.81	21.61
Y-o-Y Gr. Rt.	-	-3.5%	137.4%	55.5%	13.9%	48.5%	11.8%	10.8%	44.5%	-0.9%
Book Value per Share (Rs.)	46.81	49.16	54.47	60.77	68.27	80.39	94.79	109.77	131.3	152.25
Adjusted Net Profit	3.3	3.2	7.6	11.7	13.4	19.9	27.2	30.2	43.6	43.2
Net Op. Cash Flow (Rs. Cr.)	-33.6	10	4.3	9.2	8.8	28.9	17.8	21.3	51.1	70.7
Debt to Cash Flow from Ops	-1.35	6	14.13	5.55	5.49	2.09	2.98	2.63	0.66	0.07

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Lincoln Pharmaceuticals Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Lincoln Pharmaceuticals Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	9.5%	11%	7.3%	6.5%
Adjusted EPS	30.1%	21.4%	16.6%	-0.9%
Book Value per Share	14	17.4	17.1	16
Share Price	27%	8.7%	1.8%	75.8%

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Equity (%)	5.11	4.06	8.94	12.5	12.71	15.9	16.59	14.75	18.09	15.24
Operating Profit Margin (%)	5.69	7.71	8.32	9.19	10.45	10.59	13.95	14.21	17.14	15.92
Net Profit Margin (%)	1.99	1.82	3.94	5.63	5.99	6.39	8.95	9.29	12.36	11.49
Debt to Equity	0.59	0.75	0.69	0.51	0.43	0.46	0.28	0.26	0.13	0.02
Working Capital Days	208	264	270	272	248	168	198	221	223	227
Cash Conversion Cycle	78	74	69	74	108	93	93	94	90	80

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	37.26%
Non-Institutions	62.74%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Lincoln Pharmaceuticals Ltd a good quality company?

Data is not available for this company.

2. Is current market price of Lincoln Pharmaceuticals Ltd a good price to buy it?

The 5-year analysis of Lincoln Pharmaceuticals Ltd's performance infers:

Lincoln Pharmaceuticals Ltd earnings have grown by 21.4%, whereas share price has appreciated 8.7% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

3. What is Lincoln Pharmaceuticals Ltd share price return in the past 10 years ?

We analysed the performance of Lincoln Pharmaceuticals Ltd share prices over the last 10 years. Here is what we found out:

Lincoln Pharmaceuticals Ltd share price has appreciated 21.4% annually over the past ten years.

About Company

Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad. The plant spreads across 30,000 square meters. There are three different buildings for tablets, capsules and injectables and also a separate building for quality control.

An ultramodern laboratory with state-of-the-art equipments ensures in-house quality assurance of each of the products. The products are designed for all therapeutic segments with a special emphasis on gynecological and orthopedic specialties.

Group of Companies